chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Myocarditis, Symptoms headache general start 02/16/2006 end 02/18/2006 bad headaches x 3 days (unusual for patient behind eyes, pounding pain and started in afternoon with gradual worsening until HS, no relief with two Aleve. Chest pain substernal start 2/18/2006 initial episode brief after going up flight of stairs, woke up with CP that persisted x 2-3 hours the next day. CP dull pressure. Dyspnea (shortness of breath) start 2/18/2006 initial onset after climbing flight of stairs, woke with mild dyspnea the next day that worsened with activity. chills start 2/19/2006 experienced shaking shivering and chills and alternating sensation of being hot and cold (on drive to hospital in early AM). numbness start 2/19/2006 experienced circumoral numbness and arms felt numb during drive to hospital in early arm. Nausea w/o vomiting start 2/19/2006 experienced nausea when pain at its peak and while in ER. 05/08/06-received 35 page medical record from VHC and 7 page follow-up clinic visit. Hospitalized from 2/19-2/21/06-DC DX vaccinia related myopericarditis-presented with c/o chest pain, elevated troponin level 2.6,  EKG normal, echo normal.  Follow-up Report April 14, 2006: Patient remains asymptomatic. Enclosed are medical records from hospital as well as records from his recent outpatient Cardiology evaluation at medical center.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 28-DEC-2015 the patient was vaccinated with an improperly stored dose of GARDASIL (lot # K016966, expiration date 10-MAY-2017, dose and route not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion. The total cumulative excursion time was 48 hours, the lowest recorded temperature was 34 Farenheit degree and the type of excursion was refrigerator (R). The storage criteria was R. This is one of several reports received from the same source. Additional information has been requested.
pt recvd vax & did not seroconvert; pt recvd a booster dose of Engerix-B in APR92 & 6 hrs later devel resp sx; pt dx w/pneumonia the following day; pt still did not seroconvert p/the booster dose of Engerix-B;
This pt has Hirschsprung. Had pull through procedure on 1-4-12. ROTARIX on 1-18-12 (his 1st) same day developed abdominal symptoms & developed severe enterocolitis -megacolon toxic. Was on ventilator - recovered.
when requesting booster patient disclosed receiving 4 doses. Patient received 2 doses of astra zeneca also received 2 doses of pfizer .
Lump (L) arm, noted day after GARDASIL immunization. Resolved after 10 days and then recurred 4 weeks after initial immunization. Pt. also noticed increased nausea x 1 month starting the day after the immunization.
Itching and redness at the injection site size measuring 6.5cm x 8cm
Daughter had the GARDASIL vaccination on Monday. That night she felt nauseous, dizzy and thought she was going to throw up. She went to school on Tuesday and felt terrible. The symptoms really kicked in on Wednesday and she stayed home from school. She didn't eat anything and just was in so much pain. Thursday she tried to go to school and made it a half day before coming home. Called the GI doc, she recommended ZANTAC. We tried that, no relief. Burning stomach pain, nausea, dizziness still happened. She is trying to go to school today but she really feels awful. This was her final dose. She had a milder form of this with her first two, but nothing like this.
Low grade fever - rash covering most of body sick to my stomach itchy these symptoms lasted 5 days.
Swelling & slight soreness at site of injection.; Swelling & slight soreness at site of injection.; Goose egg size swelling.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Oct2021 11:00 (Lot number: 30155BA) at the age of 69 years as dose 3 (booster), single for covid-19 immunisation; tetanus vaccine (TETANUS VACCINE), administered in arm left, administration date 07Oct2021 (Batch/Lot number: unknown). Relevant medical history included: "Mild asthma" (unspecified if ongoing); "Mild hypertension" (unspecified if ongoing); "Chronic pain due to arthritic knees" (unspecified if ongoing); "Excessive PVCs currently under control through medication" (unspecified if ongoing); "Obesity" (unspecified if ongoing); "Back Pain" (unspecified if ongoing); "Back stenosis" (unspecified if ongoing); "some finger joints pain" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: El3259, Location of injection: Arm Left, Did not have any adverse reaction to the first two Pfizer COVID-19 shots), administration date: 08Feb2021, when the patient was 69 years old, for COVID-19 immunization, reaction(s): "Did not have any adverse reaction to the first two Pfizer COVID-19 shots"; Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9265, Location of injection: Arm Left, Did not have any adverse reaction to the first two Pfizer COVID-19 shots), administration date: 18Jan2021, when the patient was 68 years old, for COVID-19 immunization, reaction(s): "Did not have any adverse reaction to the first two Pfizer COVID-19 shots".  The following information was reported: VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PAIN (non-serious) all with onset Oct2021, outcome "not recovered" and all described as "Swelling & slight soreness at site of injection."; SWELLING (non-serious) with onset Oct2021, outcome "not recovered", described as "Goose egg size swelling.". Therapeutic measures were not taken as a result of vaccination site swelling, vaccination site pain, swelling.  Additional information: Adverse event start time: 07:00 PM. Hospitalization was not Prolonged. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no known allergies.  Follow-up attempts are completed. No further information is expected.
covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced COVID-19 (covid-19). At the time of the report, COVID-19 (covid-19) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.  Action taken with mRNA-1273 Moderna vaccine was Not applicable
devel flu like sx lasting 24-48hr p/each inj; 7 wk p/4/15/99, devel aching, episodic pain popliteal fossae radiating into calves & ankles; has inc frequency & duration, relieved by massage; tx: observation, muscle relaxant; knee pain cont;
Woke up about 12 hours after vaccination with the ball of my left foot mostly numb. Never had this symptom before and can't attribute it to anything else directly. 6 hours later the numbness is reduced but still present. Have a slight headache and sore at site of injection. No other complaints.
its been a year since I contacted your reporting adverse program with my issues and along with the medical professionals dont seem to hear me; 64 year old patient; This case was retrieved during the monitoring on 11-Apr-2022 with the following reference number: 2070121-1. The original narrative from the sender is as follows.  It's been a year since I contacted your reporting adverse program with my issues and along with the medical professionals don't seem to hear me.
Patient called today complaining of body itching, itchy eyes and fatigue.  She has been taking Benadryl every 6 hours. Patient will start regimen which includes antihistamines and Medrol dose pack. If symptoms worsen go to ER.
PT was eating lunch today, jello, and began having an episode of shaking, upper body with more tremor movements, eyes glazed over not deviated, left leg stiffened somewhat, episode last for approx 60 seconds, no coughing or choking during episode, no incontinence, did not respond for episode but was reaching for his milk during that time, after episode did not walk immediately but did not have any postictal period, began running around, has since eaten some more , playing, acting normally, episode happened about 1 hr prior to visit, did have 2 yr WCC today, influenza and Hep A vaccines given
Rash on extremities, hive on face & arm, red burning hands, knees swelling & hot. Injection site hot, throat irritation, (itching generalized). Ears hot & red, tremors.
Swelling, redness, warm to touch, hard, at injection site, feverish feeling.  Symptoms increased over the next 48 hrs with size increasing & redness spreading down arm.
Vial of Moderna was removed from deep freeze on 9/9/2021 the beyond use date was established as 10/8/21. Patient received this vaccine on 10/18/21
fatigue, headache, chills/sweats, dyspnea, left arm and axilla pain
Pt stated that upon injection, she felt a sharp, hot pain similar to an ice pick or hot poker stick stabbing her. About 4 hours later, the area became hard and stiff and painful and she began to see a rash. She took an Ibuprofen which didn't help, and put ice on the sore area, coconut oil and witch hazel on the rash. She felt nauseous and began feeling body aches and reported she stayed in bed the next day. She could not lie on that arm at night due to the area being very painful. She reported the rash lasted about 2.5 weeks, the rash was not itchy, but was red with little bumps about 4 x 6 inches in area. The area also remained very tender to touch during the 2.5 weeks.
I felt like my neck had pain; Same night 11:30PM I could not move my hand; My left eye was swollen above the eye; Arm easily gets tired; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (I felt like my neck had pain), HYPOKINESIA (Same night 11:30PM I could not move my hand), EYE SWELLING (My left eye was swollen above the eye) and FATIGUE (Arm easily gets tired) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     Concomitant products included METFORMIN and GLIPIZIDE for Diabetes mellitus.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-May-2021, the patient experienced NECK PAIN (I felt like my neck had pain), HYPOKINESIA (Same night 11:30PM I could not move my hand), EYE SWELLING (My left eye was swollen above the eye) and FATIGUE (Arm easily gets tired). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) for Pain, at an unspecified dose and frequency and BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORIN TOPICAL) at an unspecified dose and frequency. At the time of the report, NECK PAIN (I felt like my neck had pain) had not resolved and HYPOKINESIA (Same night 11:30PM I could not move my hand), EYE SWELLING (My left eye was swollen above the eye) and FATIGUE (Arm easily gets tired) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Event outcome updated from unknown to not recovered for neck pain and unknown to recovered/resolved for the other events.
I had typical soreness in the arm about 6 hours later. Its lessening today. I was short of breath 24 hours after receiving the vaccine and I have been getting dizzy 48 hours after receiving the shot.
Hospitalized came in for heartburn and suffered cardiac arrest during exam. COVID + 1/19/2022.
Patient developed local swelling and urticaria developed severe flu like illness with nausea, malaise lasting several days.
This spontaneous case reported by an other healthcare professional, describes the occurrence of administered expired product (vaccine expired and administered to a patient) and product storage error (vial open for over 12 hours, 22 and a half hours) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 035C21A) for COVID-19 immunization. No medical history reported. On Oct 21, 2021, at 11:40, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Oct 21, 2021, patient administered expired product (vaccine expired and administered to a patient) and product storage error (vial open for over 12 hours, 22 and a half hours). On Oct 21, 2021, administered expired product (vaccine expired and administered to a patient) and product storage error (vial open for over 12 hours, 22 and a half hours) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information. Reportedly, the vial initially stored in refrigerator on Oct 20, 2021 and first punctured on Oct 20, 2021 around 12 pm. The vial did not undergone any temperature excursions. The reporter stated the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F) for around 1 hour.
Around 2 PM today she developed tingling in her right fifth finger while driving. She states approximately 15 minutes earlier she had gotten a tetanus shot. She states that the tingling had persistent throughout the evening but she went to work and noted the tingling only when she tried to start an IV. At approximately 8 PM she developed sudden onset sensation that her heart was beating faster and developed tingling on the palms of her hands and feet bilaterally. The palpitations resolved but she still has tingling sensation on her hands and feet. She denies any other symptoms. She specifically denies any rash, throat swelling, difficulty breathing, dizziness, syncope, chest pain, or shortness of breath. She also denies any headache, confusion, speech or vision changes, weakness, loss of balance, or any other paresthesias other than in her hands and feet.
Right side of face numbness. Described as if had received novacaine. Progressed to neck and head. This lasted about 2 hours.
Severe Restless Legs for 2 days. Severe Leg Joint Paint for 2 weeks. Walking very difficult and painful for 2 weeks. Unable to run again for 2 months.
Headache, Myalgia, Arthralgia, NauseaVomiting, Chills, Fatigue, Rigors, Injection site pain Narrative:  Patient was COVID positive ~2 months prior to receipt of vaccine (12/18/20). Patient visited urgent care in response to the  symptoms experienced after receipt of vaccine.   Other Relevant History:
My period went from being regular to so unpredictable that I actually went to the doctor to see if I had cancer. In talking with friends, others said they had the same experience after the covid vaccine. I don?t know if it is related, but I wanted to report this because it is something they should tell people when getting the vaccines if it is an issue. I either am very late, by over a week, or super early, in the sense that I will get my period, finish a week later, but have heavier flow than before. Then, a week after it finishes, I will get my period again. I seriously thought I had cancer and got biopsies because it was so concerning. My period, regardless of when I get it, is way heavier than before every time.   My period is still irregular 6 months later.
Sharp pain in heart. Hard to breathe and have to sit down, only lasts about 5 minutes at a time
I went to PCP had a problem with the diagnosis of ringworm. They found it was a rash I was prescribed Prednisone. When I ran out of my medication the rashes came back. I went to the Dermatologist they thought it was associated with the vaccine. I was prescribed Triamcinolone ointment and advised to take Allegra in the morning and take Zyrtec at night. This is 10 months later I'm still experiencing these rashes.
Headache, Fever, SkinRash, Diarrhea, Chills, flushing, throat felt scratchy/ swollen Narrative:
w/in 15 mins of admin pain in lt arm progressing to shoulders, back & neck by 9AM; 930AM h/a &nausea; 1Pm pain lt ribcage, chills, & lg swelling LD; 3PM pain down back & into hips legs; could barely move; 12MAR94 7AM soreness in jaws;
Temp 100.5, no vomiting. Pain worse when moves ( L ) arm. Indurated area 5 cm. Normal grip sensory exam.
Consistent Migraines for 14 days now.   Started December 1st, the morning after Vaccination. Dec 5th went to doctor for consistent migraine, advised rest, pain meds and liquids. Dec 10th blurry spot in vision and increased intensity of Migraine, waking at night from pain.  Went back to PCP and was advised 3 days of rest, fluids and pain meds.  PCP was contacting Neuro for advice. Dec 11th went to ER on recommendation of PCP.  Had MRI which was clear.  Migraine cocktail was given and were sent home with prescription for Naproxen and Rizatriptan. Dec 12th felt better as pain decrease, took Naproxen but headache still present. Dec 13 increased headache, took Naproxen and Rizatriptan. Dec 14th woke with intense headache and blurry vision returned.  Took Naproxen and Tylenol.  Saw eye doctor.
Sore arm, headache, upset stomach 14 hours after injection. Loss of appetite and upset stomach for 48-60 hours.
Pt admitted on 3/2 due to ischemic CVA due to global hypoperfusion and watershed infarction. He was tested for COVID on 3/3 due to nursing home placement and was found to be COVID positive. Pt is asymptomatic.
COVID 19; COVID 19; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4365970-00 (Agency).  A 38-year-old male patient received BNT162b2 (BNT162B2), on 10Jan2021 as dose 1, single (Batch/Lot number: unknown) at the age of 37 years intramuscular for covid-19 immunisation; adalimumab (HUMIRA), first regimen (Lot number: 1157583) at 80 mg 1x/day (citrate free day 1 (1 in 1 d)), second regimen (Lot number: 115783) at 40 mg 1x/day (citrate free day 8 (1 in 1 d)) and third regimen (Lot number: 115783) at 40 mg (citrate free (40 mg,1 in 2 wk)), all subcutaneous. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Jan2021, outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: UNKNOWN. The action taken for adalimumab was unknown.  The reporter's assessment of the causal relationship of "covid 19" with the suspect product(s) BNT162b2 was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information, there is a reasonable possibility of a causal relationship between the suspect vaccine BNT162B2 (COMIRNATY) and reported events Drug ineffective and Suspected COVID - 19 which cannot be fully assessed/excluded. The case will be reassessed if additional information becomes available.
Dosed 16 year old with Moderna Vaccine; A spontaneous report was received from a physician concerning an adolescent (16 or 17 year-old) patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced dosed 16 year old with Moderna vaccine.     The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unspecified date in Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for COVID-19 prophylaxis.   On an unspecified date in Dec 2020, a 16 or 17 year-old patient was dosed with the Moderna vaccine. After vaccination, there were no untoward effects and it was tolerated well. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   The event, dosed 16 year old with Moderna vaccine, was considered resolved on an unspecified date in Dec 2020.; Reporter's Comments: This case concerns a 16-17 year-old, patient who received their first of two planned doses of mRNA-1273 (Lot-# and expiration date -unknown), reporting an unexpected event of product administered to patient of inappropriate age without any associated adverse events. This event occurred the same day of vaccine administration. The reporter did not provide the causality assessment for the event. The event is assessed as not related to Moderna COVID-19 Vaccine.
This spontaneous report as received from a healthcare worker refers to a 14 year old patient of unknown gender. The patient's medical history and current conditions were not provided. On 01-JUN-2015, the patient was vaccinated with a dose of improperly stored GARDASIL (strength, dose and route were not provided) lot # K007828 expiration date 02-MAR-2017. Concomitant medication was not reported. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
14:30 8/22/03 presents to office with 14cm of erythema from acromron process left shoulder to mid-humerus distally uncompassing anterior-latero 1/2 of humeral surface.
A spontaneous report has been received from a Health Professional concerning a patient of unknown age and gender. who has been receiving nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started during OCT 2014. Patient received FLUMIST Quadrivalent after vaccine taken outdoors on excursions, exposed to a wide range of temperature change during OCT 2014. The outcome of the event of 5 patients received FLUMIST Quadrivalent after vaccine taken outdoors on excursions, exposed to a wide range of temperature change is unknown. The report was considered to be non-serious by the company physician.
This spontaneous report as received from a nurse refers to unspecified patients of unknown age and gender. The patient's pertinent medical history was not reported. On an unknown date, the unspecified patients were vaccinated with two doses of improperly stored VARIVAX (Merck) (dose/frequency: unspecified). No adverse effects were reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). Additional information is not expected as the reporter did not wish.
17MAY94 lt arm red, warm w/rash 1/2 dollar size @ site of inject; 18MAY94 arm better; 19MAY94 arm almost nl today;
Pt should have recieved Fluarix but instead recieved FluBlok. Followed up with patient's mother. No adverse effects or symptoms reported. Follow-up occured on 12/20/2020 at 1030 AM.
This is a spontaneous report from a contactable physician via Pfizer sales representative. A 65-year-old female patient received PREVNAR 13, (batch/lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced multiple red welts on the same arm where she received pneumococcal 13-val conj vac (dipht crm197 protein). Red welts lasted for 2 weeks. The outcome of the event was recovered. The information on the batch/lot number and expiration date has been requested.
Patient reported a headache, not being able to change her clothes without pain. The hair on her neck felt like needles and hurt. She felt run down even more than what the flu could do. Pain in her back. Very painful, couldn't move her arm for 48 hr. Patient reports aching all over when she touched anywhere on her body. She got the chills, was cold, and very tired all day on Saturday. Slept all day since it wore her out. She started to feel better on Monday 5/6/19.